Opportunities in the oligonucleotide synthesis market include increased demand for personalized therapies, growth in contract synthesis services, expanding capabilities in large-scale oligonucleotide ...

RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...

In today’s competitive biotechnology landscape, control and speed define success for companies and core labs producing synthetic genes. Yet many gene synthesis teams still rely on outsourced oligo ...

PlainID, the leading provider of policy-based authorization solutions, announced its inclusion as a Representative Provider ...

BingX, a leading cryptocurrency exchange and Web3 AI company, hosted its exclusive affiliate gathering in Tenerife, Spain, uniting leading affiliates from different regions, key partners, and BingX ...

IQ Consortium experts explain how advanced chromatographic and analytical strategies are improving the bioanalysis, ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

Offering includes Animal Origin-Free Preps, Transfection-Grade Preps and Target Yield with turnaround time starting at four business days for Express GenesEnables nucleic acids therapeutics research, ...

Professor Dongsheng Liu of Tsinghua University, Professor Ziyang Hao of Capital Medical University, and Researcher Yuanchen Dong of the Institute of ...

As 2026 approaches, rising complexity, geopolitical pressures and new modalities are reshaping strategy, capacity and CDMO ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

A review article discussed the expanding role of biologics in treating components of metabolic syndrome, including glucagon-like peptide 1 (GLP-1) analogs for type 2 diabetes and obesity and ...